HIMS - Wait for it, don't rush itI would wait for the correction to complete around the 45 zone, then start adding when the parallel channel breaks. It has already faked out once. Do not fall for this.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.666 CHF
114.47 M CHF
1.34 B CHF
200.49 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Founded
2017
FIGI
BBG01SJ2S8M0
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Related stocks
Where is HIMS set to go next?Overview of Hims & Hers Health (NYSE: HIMS):
Pros
Expanding into weight-loss treatments
-Hims successfully entered the high-demand GLP‑1 weight-loss space by selling compounded semaglutide during shortages. With branded Wegovy now available on their platform in partnership with Novo Nordisk
$HIMS | Direction: Long | Key Reason: Macro | (June 19, 2025) NYSE:HIMS | Direction: Long | Key Reason: Macro & Technical | (June 19, 2025)
1️⃣ Insight Summary
We’re watching for a healthy pullback into the $31–$30.10 zone on NYSE:HIMS before entering. That drop should align with both fundamental value and technical support, setting the stage for a stron
HIMS- possible breakout as stock held 21 EMAHIMS - Stock after massive uptrend last month. stock has been consolidating and holding above 21 EMA support level. looking for more upside above $58 for a move towards $65 and $78, calls above $58 and $60 looking good. Stock is decent at indicators
HIM $39?Company has been doing great but failed to break the $67 resistance.I see a FVG just stopping at the order block for $39. Seems like a good rebound to capitalize. I do not see this company going down unless is a really short bounce to cover inbalances.
HIMS – Technically and Fundamentally Strong for Mid-to-Long TermTechnical Analysis
HIMS is trading in a clear ascending channel since 2023.
On the daily chart, a “cup and handle” formation has completed, with a confirmed breakout above the neckline ($55–$57 area).
The price is consolidating near the breakout point – classic behavior before a continuation move
HIMS – Long Setup | Potential 60% MoveHims & Hers (HIMS) just gave us a textbook Ichimoku breakout and is holding strong above the cloud after a healthy pullback.
Technical Breakdown:
Price above Kumo Cloud: Bullish structure intact.
Support held at $54.62 – key base above cloud and Tenkan-sen.
MACD is curling back after a corrective
$HIMS setting up for its next big move—here’s what I’m watching!🔥 NYSE:HIMS setting up for its next big move—here’s what I’m watching! 🔥
📉 Eyeing momentum down to $44-$48, and I’m not mad about it!
🔄 That flip from resistance to support is key for long-term price growth.
🚀 Bull flag breakout could come sooner—stay locked in! Keeping an eye on it all for the n
Quick View: $HIMS- Bullish crossover on the hourly chart with low-volume pullback.
- Bullish daily chart Area of $58-$59 as key resistance.
Support → $50
HIMS Weekly Options Outlook — June 3, 2025📉 HIMS Weekly Options Outlook — June 3, 2025
🚨 AI Model Consensus: Moderately Bearish into June 6 Expiry
🧠 Model Overview
🔹 Grok (xAI)
Bias: Neutral
Setup: Bearish short-term, bullish long-term; mixed outlook
Trade: No action — lacks edge
Confidence: 35%
🔹 Claude (Anthropic)
Bias: Moderately
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of HIMS is 44.759 CHF — it has decreased by −0.87% in the past 24 hours. Watch HIMS & HERS HEALTH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange HIMS & HERS HEALTH stocks are traded under the ticker HIMS.
We've gathered analysts' opinions on HIMS & HERS HEALTH future price: according to them, HIMS price has a max estimate of 69.89 CHF and a min estimate of 23.02 CHF. Watch HIMS chart and read a more detailed HIMS & HERS HEALTH stock forecast: see what analysts think of HIMS & HERS HEALTH and suggest that you do with its stocks.
HIMS reached its all-time high on May 19, 2025 with the price of 51.566 CHF, and its all-time low was 21.173 CHF and was reached on Apr 22, 2025. View more price dynamics on HIMS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HIMS stock is 0.88% volatile and has beta coefficient of 3.24. Track HIMS & HERS HEALTH stock price on the chart and check out the list of the most volatile stocks — is HIMS & HERS HEALTH there?
Today HIMS & HERS HEALTH has the market capitalization of 11.74 B, it has decreased by −1.08% over the last week.
Yes, you can track HIMS & HERS HEALTH financials in yearly and quarterly reports right on TradingView.
HIMS & HERS HEALTH is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
HIMS earnings for the last quarter are 0.18 CHF per share, whereas the estimation was 0.11 CHF resulting in a 65.41% surprise. The estimated earnings for the next quarter are 0.13 CHF per share. See more details about HIMS & HERS HEALTH earnings.
HIMS & HERS HEALTH revenue for the last quarter amounts to 518.76 M CHF, despite the estimated figure of 476.79 M CHF. In the next quarter, revenue is expected to reach 449.24 M CHF.
HIMS net income for the last quarter is 43.81 M CHF, while the quarter before that showed 23.64 M CHF of net income which accounts for 85.34% change. Track more HIMS & HERS HEALTH financial stats to get the full picture.
No, HIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 21, 2025, the company has 1.64 K employees. See our rating of the largest employees — is HIMS & HERS HEALTH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIMS & HERS HEALTH EBITDA is 122.11 M CHF, and current EBITDA margin is 5.76%. See more stats in HIMS & HERS HEALTH financial statements.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIMS & HERS HEALTH stock right from TradingView charts — choose your broker and connect to your account.